V
4.46
0.51 (12.91%)
| Penutupan Terdahulu | 3.95 |
| Buka | 3.99 |
| Jumlah Dagangan | 1,897,928 |
| Purata Dagangan (3B) | 740,944 |
| Modal Pasaran | 198,498,992 |
| Harga / Jualan (P/S) | 13.54 |
| Harga / Buku (P/B) | 16.31 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2024 |
| Margin Operasi (TTM) | -1,145.05% |
| EPS Cair (TTM) | -3.14 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 128.59% |
| Nisbah Semasa (MRQ) | 3.23 |
| Aliran Tunai Operasi (OCF TTM) | -109.35 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -32.02 M |
| Pulangan Atas Aset (ROA TTM) | -47.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -136.87% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Verastem, Inc. | Menurun | Menurun |
AISkor Stockmoo
-1.5
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | -5.0 |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -1.5 |
| Purata | -1.50 |
|
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 0.83% |
| % Dimiliki oleh Institusi | 59.93% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 13.00 (RBC Capital, 191.48%) | Beli |
| Median | 9.00 (101.79%) | |
| Rendah | 7.00 (HC Wainwright & Co., 56.95%) | Beli |
| Purata | 9.67 (116.82%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 3.95 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 19 Dec 2024 | 7.00 (56.95%) | Beli | 4.44 |
| 18 Oct 2024 | 7.00 (56.95%) | Beli | 2.96 | |
| Mizuho | 19 Dec 2024 | 9.00 (101.79%) | Beli | 4.44 |
| RBC Capital | 18 Oct 2024 | 13.00 (191.48%) | Beli | 2.96 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| CALKINS DANIEL | - | 3.90 | -28 | -109 |
| Jumlah Keseluruhan Kuantiti Bersih | -28 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -109 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 3.90 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| CALKINS DANIEL | Pegawai | 24 Dec 2024 | Jual (-) | 28 | 3.90 | 109 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |